top of page
  • Writer's pictureFutureMeds

FutureMeds Increases Investment in Ukraine’s Future by Acquiring Medical Centre "Pulse"

The freestanding clinic has provided patient care since 1995 and has conducted over 100 trials. The experienced team brings valuable insights and a rich legacy of dedication to clinical research. We at FutureMeds are proud to welcome them into our family.

Medical Centre "Pulse" is a freestanding clinic located in Vinnytsia, a city with a population of over 370,000 situated southwest of Kyiv. Established by Professor Yurii Mostovoi, a highly qualified specialist in diagnosing and treating diseases of the respiratory organs and heart, the clinic has provided quality medical care to patients since 1995.

In the last ten years (2013-2023), the team that conducted about 100 trials has been recognised as a Prime Site for IQVIA and a Partner site for Sanofi due to their capability to deliver good enrollment rates, exemplary quality and successful participation in clinical trials across various Therapeutic Areas (TAs).

Over the past decade (2013-2023), the team has conducted around 100 trials and has established a solid track record of achieving consistently high enrollment rates. Due to their commitment and ability to successfully participate in clinical trials across various therapeutic areas, they have been recognised as a Prime Site for IQVIA and a Partner site for Sanofi.

“I wish to express my heartfelt gratitude to our investors for their trust in our vision and our leadership team in Ukraine. This acquisition represents more than just growth; it symbolises our unity with Ukraine and its people and our optimism for a bright future. As we move forward, I am confident this site will provide immense value to our clients and the global clinical trials industry.”

- Radoslaw Janiak, CEO at FutureMeds

During the transition and integration period, on top of his existing duties, Dr Ivan Vyshnyvetskyy, Managing Director at FutureMeds Ukraine, will assume the Site Director role. He will be supported by Dr Andrii Sidorov, who will take on the position of Deputy Site Director. Dr Sidorov has over 14 years of clinical research experience and has overseen nearly 70 trials to date.

“Becoming a part of FutureMeds is a significant milestone for our site. As part of the site network our team will have more opportunities to showcase our expertise and deliver even more world-class quality clinical research.”

- Dr Andrii Sidorov, PhD, Deputy Site Director at Medical Centre “Pulse”

About the site and the team

The site brings together 17 investigators and study coordinators, including 5 Principal Investigators across Cardiology, Rheumatology, Pulmonology, and Gastroenterology.

Besides research, the site offers outpatient medical care in Internal Medicine, Pulmonology, Cardiology, Rheumatology, Endocrinology, Gastroenterology, Gynecology and Diagnostics to improve patient health.

“I eagerly look forward to working with them, supporting their growth and development. Together, we are committed to fostering an environment where research thrives, patients receive the utmost care and have access to future medicines, and our clients obtain solutions faster.”

- Ivan Vyshnyvetskyy, Managing Director at FutureMeds Ukraine

About the region

The Vinnytsia patient community is known for its keenness to participate in trials. To help them access new treatments and trials, the clinic established strong partnerships with healthcare institutions and professionals, underscoring their commitment to looking after the community.

The site has a core database of around 1,300 ex- and current trial participants and access to approximately 30,000 trial-naive patients. With FutureMeds @home, our DCT solution, the site will be able to reach approximately 650,000 people in its extended catchment area.

Plans for the near future

Medical Centre “Pulse” is FutureMeds’ third dedicated research site in Ukraine and is an excellent fit for our vision of building a strong network of professional research clinics that deliver high-speed recruitment, quality and patient experience in the region.

With speciality Therapeutic Areas encompassing Internal Medicine, Endoscopy, Ultrasound Diagnostics, Gynecology, Pulmonology, Cardiology, Rheumatology, Endocrinology, Gastroenterology, Urology, and Neurology, Medical Centre “Pulse” is poised to be a valuable addition to the FutureMeds network.

Together, we look forward to forging new paths, conducting groundbreaking clinical research, and, ultimately, bringing innovative treatments to patients faster. Most importantly, we look forward to bringing trials back to Ukraine.

“Despite the challenges presented by the situation in the south-eastern region of Ukraine, our decision to invest in Vinnytsia is a clear endorsement of our confidence in the sustainable and upward trajectory of the clinical trials sector in Ukraine. It’s evident that the industry in our country is not only rebounding but is poised for significant growth.”

- Ivan Vyshnyvetskyy, Managing Director at FutureMeds Ukraine

About FutureMeds

FutureMeds is the 1st European Independent Dedicated DCT Site Network, offering high traditional trial and DCT readiness across the whole network and home nursing solutions in 18 countries.

FutureMeds’ Dedicated Research Site teams strive to accelerate study timelines, streamline processes, lower costs and improve data quality to help speed up drug development and patient access to new treatments.

Through acquisitions and a strategic focus on patient experience, FutureMeds has developed large, qualified patient pools across Europe that enable faster patient enrolment, stronger retention and more accurate results.

Follow us on LinkedIn

Follow FutureMeds on LinkedIn and join a growing group of engaged, passionate healthcare and pharmaceutical professionals who are on a mission to accelerate the drug development process and achieve regulatory approval faster so patients can safely access the very latest treatments as soon as possible.


Yorumlara kapatıldı.
bottom of page